Pharmacogenomics: Genetics for Smarter Medication Management Against COVID-19
PGxOne™ Plus is a comprehensive pharmacogenomics test that can help select appropriate medications for patients with pre-existing comorbidities (cardiovascular diseases, diabetes, chronic respiratory disease, and others), patients with high-risk genotypes, as well as helping select both medications proposed to treat COVID-19 and those involved with patient supportive care.
Pharmacogenomics Testing: A Proposed Tool to Achieve Better COVID-19 Outcome in Patients with Chronic Disease Who are Prescribed Medications
COVID-19 Associated Coagulopathies and the Medications with Pharmacogenomics Associations That Are Used to Mitigate Them
PGx Testing: A Proposed Tool to Reduce Morbidity and Mortality in Patients Prescribed Chloroquine and Hydroxychloroquine for COVID-19
RxVision™, Admera Health’s Clinical Decision Support System for Physicians
- Gain digital access to all patients’ PGxOne™ Plus results even without an EMR integration
- Easily navigate test results with dynamic searches, including by medication, therapeutic area, and drug interactions
- Securely and easily refer a patient’s report to another physician
Healthcare professionals may utilize a courtesy consultation with a pharmacogenomics expert, Monday through Friday 8 am to 6 pm EST by calling 
844-4ADMERA (844.423.6372), or by scheduling 
a call.
Sample Submission Guidelines – PGxOneTM Plus
The following video, produced by DNA Genotek, will review proper techniques for collecting a buccal or cheek swab sample for processing in our laboratory in three easy steps. This will reduce the need for resample and is critical to yield good test results.